{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:54:22Z","timestamp":1759042462951},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12888-014-0361-1","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T11:09:52Z","timestamp":1419332992000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Substance use in people at clinical high-risk for psychosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Debra A","family":"Russo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Stochl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Painter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter B","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,24]]},"reference":[{"key":"361_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/schbul\/sbm015","volume":"33","author":"AR Yung","year":"2007","unstructured":"Yung AR, Yuen HP, Berger G, Francey S, Hung TC, Nelson B, Phillips L, McGorry P: Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr Bull. 2007, 33: 673-681. 10.1093\/schbul\/sbm015.","journal-title":"Schizophr Bull"},{"key":"361_CR2","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2011.1472","volume":"69","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P: Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012, 69: 220-229. 10.1001\/archgenpsychiatry.2011.1472.","journal-title":"Arch Gen Psychiatry"},{"key":"361_CR3","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/schbul\/sbr196","volume":"38","author":"JT Wigman","year":"2012","unstructured":"Wigman JT, van Nierop M, Vollebergh WA, Lieb R, Beesdo-Baum K, Wittchen HU, van Os J: Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity - implications for diagnosis and ultra-high risk research. Schizophr Bull. 2012, 38: 247-257. 10.1093\/schbul\/sbr196.","journal-title":"Schizophr Bull"},{"key":"361_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.schres.2013.05.026","volume":"148","author":"C Hui","year":"2013","unstructured":"Hui C, Morcillo C, Russo DA, Stochl J, Shelley GF, Painter M, Jones PB, Perez J: Psychiatric morbidity and disability in young people at clinical high risk for psychosis. Schizophr Res. 2013, 148: 175-180. 10.1016\/j.schres.2013.05.026.","journal-title":"Schizophr Res"},{"key":"361_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1192\/bjp.bp.111.101543","volume":"1","author":"I Kelleher","year":"2012","unstructured":"Kelleher I, Keeley H, Corcoran P, Lynch F, Fitzpatrick C, Devlin N, Molloy C, Roddy S, Clarke MC, Harley M, Arseneault L, Wasserman C, Carli V, Sarchiapone M, Hoven C, Wasserman D, Cannon M: Clinicopathological significance of psychotic experiences in non-psychotic young people: evidence from four population-based studies. Br J Psychiatry. 2012, 1: 26-32. 10.1192\/bjp.bp.111.101543.","journal-title":"Br J Psychiatry"},{"key":"361_CR6","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"21","author":"DA Regier","year":"1990","unstructured":"Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990, 21: 2511-2518. 10.1001\/jama.1990.03450190043026.","journal-title":"JAMA"},{"key":"361_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1192\/bjp.181.4.321","volume":"181","author":"RG McCreadie","year":"2002","unstructured":"McCreadie RG: Scottish Comorbidity Study Group: Use of drugs, alcohol and tobacco by people with schizophrenia: case \u2013 control study. Br J Psychiatry. 2002, 181: 321-325. 10.1192\/bjp.181.4.321.","journal-title":"Br J Psychiatry"},{"key":"361_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1192\/bjp.bp.106.024448","volume":"190","author":"JH Barnett","year":"2007","unstructured":"Barnett JH, Werners U, Secher SM, Hill KE, Brazil R, Masson K, Pernet DE, Kirkbride JB, Murray GK, Bullmore ET, Jones PB: Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry. 2007, 190: 515-520. 10.1192\/bjp.bp.106.024448.","journal-title":"Br J Psychiatry"},{"key":"361_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/bmj.332.7534.172","volume":"21","author":"DM Fergusson","year":"2006","unstructured":"Fergusson DM, Poulton R, Smith PF, Boden JM: Cannabis and psychosis. BMJ. 2006, 21: 172-175. 10.1136\/bmj.332.7534.172.","journal-title":"BMJ"},{"issue":"1","key":"361_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1600-0447.2011.01763.x","volume":"125","author":"S Dragt","year":"2012","unstructured":"Dragt S, Nieman DH, Schultze-Lutter F, van der Meer F, Becker H, de Haan L, Dingemans PM, Birchwood M, Patterson P, Salokangas RK, Heinimaa M, Heinz A, Juckel G, Graf von Reventlow H, French P, Stevens H, Ruhrmann S, Klosterk\u00f6tter J, Linszen DH, EPOS group: Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand. 2012, 125 (1): 45-53. 10.1111\/j.1600-0447.2011.01763.x.","journal-title":"Acta Psychiatr Scand"},{"key":"361_CR11","doi-asserted-by":"crossref","unstructured":"Addington J, Case N, Saleem MM, Auther AM, Cornblatt BA, Cadenhead KS: Substance use in clinical high risk for psychosis: a review of the literature. Early Interv Psychiatry 2013, doi:10.1111\/eip.12100 [Epub ahead of print].,","DOI":"10.1111\/eip.12100"},{"key":"361_CR12","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1017\/S0033291710002461","volume":"41","author":"F Cheng","year":"2011","unstructured":"Cheng F, Kirkbride JB, Lennox BR, Perez J, Masson K, Lawrence K, Hill K, Feeley L, Painter M, Murray GK, Gallagher O, Bullmore ET, Jones PB: Administrative incidence of psychosis assessed in an early intervention service in England: first epidemiological evidence from a diverse, rural and urban setting. Psychol Med. 2011, 41: 949-958. 10.1017\/S0033291710002461.","journal-title":"Psychol Med"},{"key":"361_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","volume":"39","author":"AR Yung","year":"2005","unstructured":"Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M, Francey SM, Cosgrave EM, Killackey E, Stanford C, Godfrey K, Buckby J: Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005, 39: 964-971. 10.1080\/j.1440-1614.2005.01714.x.","journal-title":"Aust N Z J Psychiatry"},{"key":"361_CR14","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998, 59: 22-33.","journal-title":"J Clin Psychiatry"},{"key":"361_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987, 13: 261-276. 10.1093\/schbul\/13.2.261.","journal-title":"Schizophr Bull"},{"key":"361_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1176\/appi.ajp.2009.09030311","volume":"166","author":"MT Compton","year":"2009","unstructured":"Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF: Relations of Pre-Onset Cannabis, Alcohol, and Tobacco Use with the Age at Onset of Prodrome and Age at Onset of Psychosis in First-Episode Patients. Am J Psychiatry. 2009, 166: 1251-1257. 10.1176\/appi.ajp.2009.09030311.","journal-title":"Am J Psychiatry"},{"key":"361_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s001270170044","volume":"36","author":"P Phillips","year":"2001","unstructured":"Phillips P, Johnson S: How does drug and alcohol misuse develop among people with psychotic illnesses? A literature review. Soc Psychiatry Psychiatr Epidemiol. 2001, 36: 269-276. 10.1007\/s001270170044.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"361_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/j.2051-5545.2008.tb00158.x","volume":"7","author":"W Hall","year":"2008","unstructured":"Hall W, Degenhardt L: Cannabis use and the risk of developing a psychotic disorder. World Psychiatr. 2008, 7: 68-71.","journal-title":"World Psychiatr"},{"key":"361_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1751-7893.2009.00133.x","volume":"3","author":"M Kamali","year":"2009","unstructured":"Kamali M, McTigue O, Whitty P, Gervin M, Clarke M, Browne S, Larkin C, O'Callaghan E: Lifetime history of substance misuse in first episode psychosis: prevalence and its influence on psychopathology and onset of psychotic symptoms. Early Interv Psychiatry. 2009, 3: 198-203. 10.1111\/j.1751-7893.2009.00133.x.","journal-title":"Early Interv Psychiatry"},{"key":"361_CR20","unstructured":"Winters KC: Assessing Alcohol Problems - A Guide for Clinicians and Researchers Second Edition NIH Publication No. 03\u20133745 Revised 2003 [ http:\/\/pubs.niaaa.nih.gov\/publications\/assessingalcohol\/index.htm ]"},{"key":"361_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","volume":"79","author":"S Leucht","year":"2005","unstructured":"Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR: What does the PANSS mean?. Schizophr Res. 2005, 79: 231-238. 10.1016\/j.schres.2005.04.008.","journal-title":"Schizophr Res"},{"key":"361_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1600-0447.2006.00900.x","volume":"115","author":"J Addington","year":"2007","unstructured":"Addington J, Addington D: Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand. 2007, 115: 304-309. 10.1111\/j.1600-0447.2006.00900.x.","journal-title":"Acta Psychiatr Scand"},{"key":"361_CR23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/070674371005500308","volume":"55","author":"S Dragt","year":"2010","unstructured":"Dragt S, Nieman DH, Becker HE, van de Fliert R, Dingemans PM, de Haan L, van Amelsvoort TA, Linszen DH: Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Can J Psychiatry. 2010, 55: 165-171.","journal-title":"Can J Psychiatry"},{"key":"361_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3109\/00048670903487118","volume":"44","author":"N Korver","year":"2010","unstructured":"Korver N, Nieman DH, Becker HE, van de Fliert JR, Dingemans PH, de Haan L, Spiering M, Schmitz N, Linszen DH: Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls. Aust N Z J Psychiatry. 2010, 44: 230-236. 10.3109\/00048670903487118.","journal-title":"Aust N Z J Psychiatry"},{"key":"361_CR25","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1017\/S0033291712000803","volume":"42","author":"AM Auther","year":"2012","unstructured":"Auther AM, McLaughlin D, Carri\u00f3n RE, Nagachandran P, Correll CU, Cornblatt BA: Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome. Psychol Med. 2012, 42: 2485-2497. 10.1017\/S0033291712000803.","journal-title":"Psychol Med"},{"issue":"8","key":"361_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1001\/jamapsychiatry.2013.1270","volume":"70","author":"B Nelson","year":"2013","unstructured":"Nelson B, Yuen H, Wood SJ, Lin A, Spiliotacopoulos D, Bruxner A, Broussard C, Simmons M, Foley DL, Brewerm WJ, Francey SM, Amminger GP, Thompson A, McGorry PD, Yung AR: Long-term follow-up of a group at ultra high risk (\u201cprodromal\u201d) for psychosis: the PACE 400 study. JAMA Psychiatr. 2013, 70 (8): 793-802. 10.1001\/jamapsychiatry.2013.1270.","journal-title":"JAMA Psychiatr"},{"key":"361_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.clinpsy.121208.131220","volume":"6","author":"E Barkus","year":"2010","unstructured":"Barkus E, Murray RM: Substance use in adolescence and psychosis: Clarifying the relationship. Annu Rev Clin Psychol. 2010, 6: 365-389. 10.1146\/annurev.clinpsy.121208.131220.","journal-title":"Annu Rev Clin Psychol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-014-0361-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-014-0361-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-014-0361-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:38:03Z","timestamp":1551184683000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-014-0361-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1186\/s12888-014-0361-1","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"361"}}